drugset / Trial / NCT00257556
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective open label, randomised, parallel group, comparative pilot.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-07
- Completion
- 2009-04
Outcome
Missed primary endpoint
registry Mean Difference (Final Values) -0.045 (95% CI -0.170 to 0.260) NCT00257556 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 150 iu | Subcutaneous |